ISHV

Cardiogenic shock is a complex, multifactorial syndrome with up to 50 percent short-term mortality. While AMI is a well-known cause, non-AMI etiologies – especially heart failure – can be more subtle and harder to detect. Patients may present with mild hypotension or fatigue yet show early signs of hypoperfusion such as rising lactate, worsening renal…

Jenny Simpson was an adventurous spirit – the kind of person who would try anything once and met life’s challenges with equanimity and calm. Jenny loved her family and friends dearly and was very giving. A resident of Richmond, VA, she worked at Giant Food for 35 years, starting as a cashier and working her…

New therapies and advances in genetic testing have changed the landscape of cardiomyopathy care, and specialized expertise can mean more healthy years for patients. The Inova Reinsch Pierce Cardiomyopathy Program provides cardiovascular care to patients with all forms of cardiomyopathy including: Whether a cardiomyopathy is common – one in 500 Americans has hypertrophic cardiomyopathy, for…

Inova MD leads creation of ACC’s concise clinical guidance The first step in solving any problem is recognizing there is one. And in the case of cardiogenic shock, that is a difficult task. Cardiogenic shock is a heterogeneous, multifactorial syndrome. While the classic acute myocardial infarction (AMI) can result in cardiogenic shock, non-AMI etiologies of…

Inova offers surgical and interventional procedures   Chronic thromboembolic pulmonary hypertension (CTEPH) is often misdiagnosed as pulmonary arterial hypertension, in part because a CTEPH diagnosis requires specialized testing including a ventilation/perfusion scan and a pulmonary angiogram, which are not widely available. Although a history of venous thromboembolic (VTE) events can predispose a patient to development…